Covance
LabCorp Expands Companion Dx Agreement With BML
The agreement will initially focus on making available assays developed and validated by LabCorp's Covance business, with the first assays targeting oncology.
LabCorp Q2 Revenues Grow Slightly, Miss Analysts Estimate
LabCorp Diagnostics was down 2.8 percent, while Covance Drug Development was up 8 percent. The firm narrowed its revenue and earnings guidance for the year.
In Brief This Week: BrainBox, LabCorp, Meridian Bio, and More
Get the latest news from BrainBox Solutions, Laboratory Corporation of America, Meridian Bioscience, Quidel, and Schott for the week of 6/7/19.
Biocartis, Covance Sign Commercialization Agreement for Idylla
Idylla molecular testing instruments will be placed at Covance sites to support customer needs for clinical trials and to validate and implement companion diagnostic applications.
Mission Bio, LabCorp Collaborate on Clinical Trials, Companion Dx Development
LabCorp's Covance business plans to offer single-cell services on Mission Bio's platform to pharma and to explore its use in companion diagnostics.